BioMarin Pharmaceutical Inc.
Price Action
Technical Summary
EMERGING TRENDBioMarin Pharmaceutical Inc. is attempting to emerge into an uptrend but lacks full moving average alignment. Relative strength is moderate (RS Rating: 50), indicating performance broadly in line with the market. Earnings contraction of 43% provides fundamental context to the price action. Volume support will be critical for the stock to resolve this consolidation to the upside.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $55.21 | +1.25% | ABOVE |
| 50 SMA | $54.25 | +3.04% | ABOVE |
| 100 SMA | $56.30 | -0.71% | BELOW |
| 150 SMA | $56.22 | -0.58% | BELOW |
| 200 SMA | $55.65 | +0.45% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is BMRN in an uptrend right now?
BMRN has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.
Is BMRN overbought or oversold?
BMRN's RSI (14) is 49. The stock is in neutral territory, neither overbought nor oversold.
Is BMRN outperforming the market?
BMRN has a Relative Strength (RS) Rating of 50 out of 99. BMRN is performing about average compared to the market.
Where is BMRN in its 52-week range?
BMRN is trading at $55.90, which is 84% of its 52-week high ($66.28) and 39% above its 52-week low ($49.26).
How volatile is BMRN?
BMRN has a Beta of 0.49 and 52-week volatility of 35%. It's less volatile than the S&P 500 - generally more stable.